Acceleron Pharma Inc. (XLRN) and trades at $178.75. The 52-week range is 177.2-179.85.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -61.2, Earnings Per Share (EPS) of $-2.92, annual revenue of $92.52M.
The stock has a beta of 0.13, operates in the Healthcare sector.
